Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

September 01, 1991; Volume 40,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderson, R

    1. You have access
      Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;
  2. Arena, J P

    1. You have access
      Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

B

  1. Balla, T

    1. You have access
      Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;
  2. Baukal, A J

    1. You have access
      Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;
  3. Begleiter, A

    1. You have access
      Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;
  4. Bisacchi, G S

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  5. Bridson, P K

    1. You have access
      Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;
  6. Bürgin, M

    1. You have access
      Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;

C

  1. Camus, J

    1. You have access
      Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;
  2. Catt, K J

    1. You have access
      Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;
  3. Christen, U

    1. You have access
      Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;
  4. Christophe, J

    1. You have access
      Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;
  5. Cully, D F

    1. You have access
      Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

D

  1. D'Angelo, D D

    1. You have access
      Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;
  2. Dudley, D T

    1. You have access
      Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;
  3. Duling, D R

    1. You have access
      Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

E

  1. Eng, S

    1. You have access
      Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;

F

  1. Farb, D H

    1. You have access
      Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;
  2. Field, A K

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  3. Furuya, H

    1. You have access
      Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;

G

  1. Gelboin, H V

    1. You have access
      Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;
  2. Gergeĺ, D

    1. You have access
      Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;
  3. Gibbs, T T

    1. You have access
      Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;
  4. Glasel, J A

    1. You have access
      Stereospecificity of opiate receptors in a synchronized culture of NG108-15 cells probed with fluorescent anti-idiotypic antibodies.
      M Ornatowska and J A Glasel
      Molecular Pharmacology September 1991, 40 (3) 354-359;
  5. Gonzalez, F J

    1. You have access
      Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;
  6. Gut, J

    1. You have access
      Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;

H

  1. Haffey, M

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  2. Hagen, M

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  3. Harrison, J K

    1. You have access
      Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;
  4. Hellwig, B

    1. You have access
      Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.
      B Hellwig and H G Joost
      Molecular Pharmacology September 1991, 40 (3) 383-389;
  5. Hubbell, S E

    1. You have access
      Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;

J

  1. Jooné, G K

    1. You have access
      Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;
  2. Joost, H G

    1. You have access
      Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.
      B Hellwig and H G Joost
      Molecular Pharmacology September 1991, 40 (3) 383-389;

K

  1. Khodorov, B

    1. You have access
      Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;

L

  1. Leith, M K

    1. You have access
      Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;
  2. Lessing, A

    1. You have access
      Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;
  3. Liu, K K

    1. You have access
      Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;
  4. Lloyd, R V

    1. You have access
      Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;
  5. Luthin, G R

    1. You have access
      Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;
  6. Lynch, K R

    1. You have access
      Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;

M

  1. Manning, D R

    1. You have access
      Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;
  2. Mason, R P

    1. You have access
      Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;
  3. Matesic, D F

    1. You have access
      Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;
  4. McGeever-Rubin, B

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  5. Meyer, U A

    1. You have access
      Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;
  6. Misík, V

    1. You have access
      Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;

O

  1. Ondrias, K

    1. You have access
      Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;
  2. Ornatowska, M

    1. You have access
      Stereospecificity of opiate receptors in a synchronized culture of NG108-15 cells probed with fluorescent anti-idiotypic antibodies.
      M Ornatowska and J A Glasel
      Molecular Pharmacology September 1991, 40 (3) 354-359;

P

  1. Pan, S S

    1. You have access
      Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;
  2. Paress, P S

    1. You have access
      Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

R

  1. Rudnick, G

    1. You have access
      Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
      G Rudnick and S C Wall
      Molecular Pharmacology September 1991, 40 (3) 421-426;
  2. Rumyantseva, G V

    1. You have access
      Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

S

  1. Sokolova, S

    1. You have access
      Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;
  2. Stasko, A

    1. You have access
      Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;
  3. Summerfelt, R M

    1. You have access
      Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;

T

  1. Tastenoy, M

    1. You have access
      Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;
  2. Terry, B

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;
  3. Tuomari, A V

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

U

  1. Uteshev, V

    1. You have access
      Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;

V

  1. Van Rensburg, C E

    1. You have access
      Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;

W

  1. Waelbroeck, M

    1. You have access
      Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;
  2. Wall, S C

    1. You have access
      Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
      G Rudnick and S C Wall
      Molecular Pharmacology September 1991, 40 (3) 421-426;
  3. Walsh, K B

    1. You have access
      Activation of a heart chloride current during stimulation of protein kinase C.
      K B Walsh
      Molecular Pharmacology September 1991, 40 (3) 342-346;
  4. Wu, F S

    1. You have access
      Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;

Y

  1. Yamanaka, G

    1. You have access
      Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

Z

  1. Zeng, D W

    1. You have access
      Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;
  2. Zilberter, Y

    1. You have access
      Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 3
1 Sep 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics